特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
618277

クレアチニンアッセイキットの世界市場の予測 (~2022年):Kinetic Jaffe法・クレアチニンPAP検査・ELISA

Creatinine Assay Kits Market by Type (Jaffe's Kinetic Test, Creatinine-PAP, and ELISA), Sample (Blood, Serum, Urine, Saliva, CSF, Tissue Homogenate, Sweat) and Region (North America, Europe, Asia and RoW) - Global Forecast to 2022

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 192 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.56円
クレアチニンアッセイキットの世界市場の予測 (~2022年):Kinetic Jaffe法・クレアチニンPAP検査・ELISA
出版日: 2018年03月21日
発行: MarketsandMarkets
ページ情報: 英文 192 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のクレアチニンアッセイキットの市場は予測期間中5.3%のCAGR (年間複合成長率) で推移し、2017年の1億8960万米ドルから、2022年には2億4540万米ドルの規模に成長すると予測されています。腎疾患の罹患率の拡大、腎機能に影響を及ぼすその他の慢性疾患の罹患率の拡大、予防的アプローチの導入に関する認知度の上昇、腎臓の健康を推進する政府によるイニチアチブの実施などの要因が同市場の成長を推進しています。

当レポートでは、世界のクレアチニンアッセイキットの市場を調査し、市場の定義と概要、市場成長への各種影響因子および市場機会の分析、クレアチニン検査の地域・タイプ別の実施件数、検査タイプ・サンプルタイプ・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要・産業動向

  • イントロダクション
  • 市場成長促進要因
  • 市場成長抑制要因・課題
  • 市場機会

第6章 クレアチニン検査の実施件数

  • イントロダクション
  • 地域別
  • タイプ別

第7章 市場分析・予測:タイプ別

  • イントロダクション
  • Kinetic Jaffe法による検査キット
  • クレアチニンPAP検査キット
  • ELISA法による検査キット

第8章 市場分析・予測:サンプルタイプ別

  • イントロダクション
  • 血液・血清
  • 尿
  • その他

第9章 地域分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他
  • アジア
    • 日本
    • 中国
    • インド
    • インドネシア
    • その他
  • その他の地域
    • ブラジル
    • その他

第10章 競合環境

  • 競合インテリジェンス
  • 市場シェア分析
  • 競合状況・動向

第11章 企業プロファイル

  • イントロダクション
  • THERMO FISHER SCIENTIFIC INC.
  • MERCK KGAA
  • ABCAM PLC
  • ABBOTT LABORATORIES
  • QUIDEL CORPORATION
  • ENZO LIFE SCIENCES, INC.
  • CAYMAN CHEMICAL
  • CRYSTAL CHEM INC.
  • CELL BIOLABS INC.
  • GENWAY BIOTECH
  • BIOASSAY SYSTEMS LLC
  • 和光純薬工業
  • TULIP DIAGNOSTICS PRIVATE LIMITED
  • BIOVISION INC.
  • ARBOR ASSAYS LLC

第12章 付録

図表

LIST OF TABLES

  • TABLE 1: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY REGION 2016 (MILLION UNITS)
  • TABLE 2: JAFFE'S KINETIC TEST: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY REGION 2016 (MILLION UNITS)
  • TABLE 3: CREATININE-PAP TEST: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY REGION 2016 (MILLION UNITS)
  • TABLE 4: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 5: JAFFE'S KINETIC TEST KITS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: NORTH AMERICA: JAFFE'S KINETIC TEST KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 7: EUROPE: JAFFE'S KINETIC TEST KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 8: ASIA: JAFFE'S KINETIC TEST KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 9: ROW: JAFFE'S KINETIC TEST KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 10: CREATININE-PAP TEST KITS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: NORTH AMERICA: CREATININE-PAP TEST KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 12: EUROPE: CREATININE-PAP TEST KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 13: ASIA: CREATININE-PAP TEST KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 14: ROW: CREATININE-PAP TEST KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 15: ELISA TEST KITS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: NORTH AMERICA: ELISA TEST KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 17: EUROPE: ELISA TEST KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 18: ASIA: ELISA TEST KITS MARKET, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 19: ROW: ELISA TEST KITS MARKET, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 20: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 21: BLOOD/SERUM SAMPLES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: NORTH AMERICA: BLOOD/SERUM SAMPLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: EUROPE: BLOOD/SERUM SAMPLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 24: ASIA: BLOOD/SERUM SAMPLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: ROW: BLOOD/SERUM SAMPLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 26: URINE SAMPLES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: URINE SAMPLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 28: EUROPE: URINE SAMPLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 29: ASIA: URINE SAMPLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: ROW: URINE SAMPLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 31: OTHER SAMPLES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: NORTH AMERICA: OTHER SAMPLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 33: EUROPE: OTHER SAMPLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: ASIA: OTHER SAMPLES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 35: ROW: OTHER SAMPLES MARKET, BY COUNTRY, 2015-2022 (USD THOUSAND)
  • TABLE 36: CREATININE ASSAY KITS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 37: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY TYPE, 2016 (MILLION UNITS)
  • TABLE 38: NORTH AMERICA: CREATININE ASSAY KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 39: NORTH AMERICA: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 40: NORTH AMERICA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 41: US: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 42: US: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 43: US: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY TYPE, 2016 (MILLION UNITS)
  • TABLE 44: CANADA: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 45: CANADA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: CANADA: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY TYPE, 2016 (MILLION UNITS)
  • TABLE 47: EUROPE: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 48: EUROPE: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 49: EUROPE: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY TYPE 2016 (MILLION UNITS)
  • TABLE 50: GERMANY: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: GERMANY: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: UK: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 53: UK: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 54: FRANCE: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: FRANCE: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: ROE: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 57: ROE: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: ASIA: CREATININE ASSAY KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 59: ASIA: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: ASIA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 61: JAPAN: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 62: JAPAN: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 63: JAPAN: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY TYPE 2016 (MILLION UNITS)
  • TABLE 64: CHINA: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: CHINA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 66: CHINA: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY TYPE, 2016 (MILLION UNITS)
  • TABLE 67: INDIA: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: INDIA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 69: INDIA: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY TYPE, 2016 (MILLION UNITS)
  • TABLE 70: INDONESIA: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD THOUSAND)
  • TABLE 71: INDONESIA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD THOUSAND)
  • TABLE 72: INDONESIA: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY TYPE 2016 (MILLION UNITS)
  • TABLE 73: ROA: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 74: ROA: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 75: ROA: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY TYPE, 2016 (MILLION UNITS)
  • TABLE 76: REST OF THE WORLD: CREATININE ASSAY KITS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 77: REST OF THE WORLD: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 78: ROW: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)
  • TABLE 79: ROW: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY TYPE, 2016 (MILLION UNITS)
  • TABLE 80: BRAZIL: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD THOUSAND)
  • TABLE 81: OTHER ROW COUNTRIES: CREATININE ASSAY KITS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 82: BRAZIL: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD THOUSAND)
  • TABLE 83: BRAZIL: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED, BY TYPE 2016 (MILLION UNITS)
  • TABLE 84: OTHER ROW COUNTRIES: CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: MARKET SEGMENTATION
  • FIGURE 2: YEARS CONSIDERED FOR THE STUDY
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: CREATININE ASSAY KITS MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: CREATININE ASSAY KITS MARKET: TOP-DOWN APPROACH
  • FIGURE 6: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY: CREATININE ASSAY KITS MARKET
  • FIGURE 8: EPIDEMIOLOGY-BASED MODEL: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED
  • FIGURE 9: BREAKDOWN OF PRIMARY INTERVIEWS: BY REGION
  • FIGURE 10: DATA TRIANGULATION METHODOLOGY: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED
  • FIGURE 11: CREATININE ASSAY KITS MARKET, BY TYPE, 2017 VS. 2022
  • FIGURE 12: CREATININE ASSAY KITS MARKET, BY TYPE OF SAMPLE, 2017 VS. 2022
  • FIGURE 13: GEOGRAPHIC SNAPSHOT OF THE CREATININE ASSAY KITS MARKET: ASIA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 14: INCREASING INCIDENCE OF RENAL DISORDERS: MAJOR FACTOR DRIVING THE GROWTH OF THE CREATININE ASSAY KITS MARKET
  • FIGURE 15: JAFFE'S KINETIC TEST KITS SEGMENT TO DOMINATE THE MARKET IN 2017
  • FIGURE 16: URINE SAMPLES SEGMENT TO DOMINATE THE MARKET IN 2017
  • FIGURE 17: GEOGRAPHIC GROWTH OPPORTUNITIES: ASIA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 18: CREATININE ASSAY KITS MARKET: DRIVERS, RESTRAINTS/CHALLENGES, AND OPPORTUNITIES
  • FIGURE 19: PRICING ANALYSIS: CREATININE TEST MARKET
  • FIGURE 20: KEY DEVELOPMENTS IN THE CREATININE ASSAY KITS MARKET, 2013-2017
  • FIGURE 21: AGREEMENTS ACCOUNTED FOR THE LARGEST SHARE OF THE TOTAL DEVELOPMENTS IN THE CREATININE ASSAY KITS MARKET (2013-2017)
  • FIGURE 22: INSIGHTS FROM INDUSTRY EXPERTS
目次
Product Code: BT 6111

The global creatinine assay kits market projected to grow at a CAGR of 5.3%.

"The global creatinine assay kits market is expected to reach USD 245.4 million by 2022 from USD 189.6 million in 2017, at a CAGR of 5.3%"

Growth in this market is mainly driven by the increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and advancements in biomedical research pertaining to kidney disorders. However, the limited usage of creatinine assay kits in IVD and identification of novel renal dysfunction biomarkers are expected to challenge market growth in the coming years.

"Creatinine-PAP test kits are expected to grow at the highest CAGR during the forecast period."

Based on type, the market is segmented into Jaffe's kinetic test kits, Creatinine-PAP test kits, and ELISA test kits. The Creatinine-PAP test kits segment is expected to grow at the highest CAGR during the forecast period. The fastest growth of this segment is attributed to the increasing demand for more accurate kits and high research funding support for renal research initiatives.

"The urine segment is expected to dominate the market during the forecast period."

Based on type of sample, the creatinine assay kits market is segmented into blood/serum, urine, and other samples. The urine segment is expected to dominate the market during the forecast period. The large share of this segment can primarily be attributed to the greater preference for urine samples owing to the ease of sample collection.

"Asia to witness the highest growth during the forecast period."

In 2017, North America accounted for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high prevalence of CKD and ESRD in this region and the presence of a large undiagnosed population are the major factors driving the growth of the creatinine assay kits market in Asia. The increasing prevalence of infectious diseases and metabolic syndromes in this region is resulting in the high and regular prescription for metabolic tests.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 33%; Tier 2 - 45%; Tier 3 - 22%
  • By Designation C-level- 22%; D-level- 28%; Others- 50%
  • By Region: North America-55%; Europe-24%; Asia -15%; Rest of the World-6%

List of companies profiled in the report:

  • Thermo Fisher Scientific (US)
  • Merck (Germany)
  • Abcam (UK)
  • Abbott Laboratories (US)
  • Quidel (US)
  • Enzo Life Sciences (US)
  • Cayman Chemical (US)
  • Crystal Chem (US)
  • Cell Biolabs (US)
  • GenWay Biotech (US)
  • BioAssay Systems (US)
  • Wako Pure Chemical Industries (Japan)
  • Tulip Diagnostics (India)
  • BioVision (US)
  • Arbor Assays (US)

Research Coverage:

The report provides an overview of the creatinine assay kits market. It aims at estimating the market size and future growth potential of this market across different segments such as type, type of sample, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall creatinine assay kits market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. INTRODUCTION
  • 2.2. RESEARCH DATA
  • 2.3. MARKET SIZE ESTIMATION: CREATININE ASSAY KITS MARKET
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPORACH
  • 2.4. BREAKDOWN OF PRIMARIES: CREATININE ASSAY KITS MARKET
  • 2.5. MARKET BREAKDOWN AND DATA TRIANGULATION: CREATININE ASSAY KITS MARKET
  • 2.6. EPIDEMIOLOGY-BASED MODEL: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED
  • 2.7. BREAKDOWN OF PRIMARIES: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED
  • 2.8. MARKET BREAKDOWN AND DATA TRIANGULATION: NUMBER OF CREATININE MEASUREMENT TESTS PERFORMED
  • 2.9. SECONDARY DATA
    • 2.9.1. KEY DATA FROM SECONDARY SOURCES
  • 2.10. PRIMARY DATA
    • 2.10.1. KEY DATA FROM PRIMARY SOURCES
  • 2.11. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DRIVERS
    • 5.2.1. INCREASING INCIDENCE OF RENAL DISORDERS
    • 5.2.2. GROWING INCIDENCE OF OTHER CHRONIC DISORDERS IMPACTING RENAL FUNCTION
    • 5.2.3. GROWING AWARENESS AND ADOPTION OF PREVENTIVE HEALTHCARE
    • 5.2.4. FAVORABLE GOVERNMENT INITIATIVES TO PROMOTE RENAL HEALTH
    • 5.2.5. RAPID GROWTH IN THE GERIATRIC POPULATION
    • 5.2.6. ADVANCEMENTS IN BIOMEDICAL RESEARCH PERTAINING TO KIDNEY DISORDERS AND AVAILABILITY OF FUNDING
  • 5.3. MARKET RESTRAINTS/CHALLENGES
    • 5.3.1. LIMITED USAGE OF CREATININE ASSAY KITS IN IVD
    • 5.3.2. IDENTIFICATION OF NOVEL RENAL DYSFUNCTION BIOMARKERS
    • 5.3.3. FREQUENTLY CHANGING REGULATORY POLICIES
  • 5.4. MARKET OPPORTUNITIES
    • 5.4.1. HIGH GROWTH POTENTIAL IN EMERGING ECONOMIES

6. NUMBER OF CREATININE TESTS PERFORMED

  • 6.1. INTRODUCTION
  • 6.2. NUMBER OF CREATININE TESTS PERFORMED, BY REGION
  • 6.3. NUMBER OF CREATININE TESTS PERFORMED, BY TYPE

7. CREATININE ASSAY KITS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. JAFFE'S KINETIC TEST KITS
  • 7.3. CREATININE-PAP TEST KITS
  • 7.4. ELISA TEST KITS

8. CREATININE ASSAY KITS MARKET, BY SAMPLE TYPE

  • 8.1. INTRODUCTION
  • 8.2. BLOOD/SERUM
  • 8.3. URINE
  • 8.4. OTHER SAMPLES

9. CREATININE ASSAY KITS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. UK
    • 9.3.3. FRANCE
    • 9.3.4. REST OF THE EUROPE
  • 9.4. ASIA
    • 9.4.1. JAPAN
    • 9.4.2. CHINA
    • 9.4.3. INDIA
    • 9.4.4. INDONESIA
    • 9.4.5. REST OF THE ASIA
  • 9.5. REST OF THE WORLD
    • 9.5.1. BRAZIL
    • 9.5.2. OTHER REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. CREATININE ASSAY KITS MARKET: COMPETITIVE INTELLIGENCE (2016)
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETETIVE SITUATION & TRENDS

11. COMPANY PROFILES

  • 11.1. INTRODUCTION
  • 11.2. THERMO FISHER SCIENTIFIC INC.
  • 11.3. MERCK KGAA
  • 11.4. ABCAM PLC
  • 11.5. ABBOTT LABORATORIES
  • 11.6. QUIDEL CORPORATION
  • 11.7. ENZO LIFE SCIENCES, INC.
  • 11.8. CAYMAN CHEMICAL
  • 11.9. CRYSTAL CHEM INC.
  • 11.10. CELL BIOLABS INC.
  • 11.11. GENWAY BIOTECH
  • 11.12. BIOASSAY SYSTEMS LLC
  • 11.13. WAKO PURE CHEMICAL INDUSTRIES, LTD
  • 11.14. TULIP DIAGNOSTICS PRIVATE LIMITED
  • 11.15. BIOVISION INC.
  • 11.16. ARBOR ASSAYS LLC

12. APPENDIX

  • 12.1. KEY INDUSTRY INSIGHTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. MARKETSANDMARKETS KNOWLEDGE STORE: SNAPSHOT
  • 12.5. INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.